Jonathan Katchmore

Jonathan Katchmore has a diverse work experience in the pharmaceutical and diagnostic industry. Jonathan is currently working as the Associate Vice President, Commercial Diagnostic Strategy at Loxo@Lilly since March 2023. Prior to this, they held the position of Precision Medicine Director, East at Eli Lilly and Company from September 2020 to March 2023. Before joining Eli Lilly, they worked at Loxo Oncology, Inc. as the Precision Medicine Director, East from January 2020 to September 2020, and as the Director, Diagnostic Account Strategy from May 2018 to January 2020. Jonathan also has experience working at Foundation Medicine as the Mid-Atlantic Regional Sales Director from July 2012 to May 2018. Before that, they worked at Myriad Genetics as an Oncology Product Specialist from September 2008 to June 2012. Jonathan's career started at sanofi-aventis, where they held roles as an Aesthetics Specialty Representative from April 2007 to January 2008 and a Urology Specialty Representative from October 2005 to April 2007. Jonathan began their career in the pharmaceutical industry as a Professional Healthcare Representative at Pfizer from January 2001 to October 2005.

Jonathan Katchmore completed their Bachelor of Science degree in Operations & Information Management from the University of Scranton, where they attended from 1992 to 1997. In 2020, they obtained a certification in Leadership Mindsets from LinkedIn.